STRS Earnings

STRS reported its earnings on 2026-02-11, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0.16% price change on the earnings day and a 3.85% change over the next five days, reflecting market reactions to the results.

Following STRS's earnings announcement on 2026-02-11, the stock price moved by 0.16% on the day of the release. Over the subsequent five days, it saw a 3.85% change. Historically, STRS's stock price tends to shift by an average of -1.04% in the 10 days leading up to earnings and +1.94% in the 10 days following, providing insight into potential market.

For , analysts estimate STRS’s annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue Go Up by 58.80% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between STRS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for were Go Up by 58.80%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, STRS's stock price typically moves by -1.04% in the 10 days before its earnings and +1.94% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call reveals mixed signals: revenue growth and strong performance in Brazil are positives, but declining gross profit margins, increased competition, and supply chain issues are concerning. The dividend declaration and improved net debt position are favorable, yet risks from economic instability and the war in Israel persist. The Q&A session highlighted growth strategies but lacked clarity on war impacts. Overall, the combination of positive financial actions and significant risks results in a neutral outlook for stock movement.